Phosphatidylinositol 4,5-bisphosphate (PIP2)

Phosphatidylinositol 4,5-bisphosphate (PIP2) is a vital phospholipid located primarily in the inner leaflet of the plasma membrane, where it serves as a central regulator of numerous cellular processes [1, 11]. It acts as a critical precursor for the generation of second messengers, including inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) via phospholipase C (PLC) hydrolysis, as well as phosphatidylinositol 3,4,5-trisphosphate (PIP3) via phosphoinositide 3-kinase (PI3K) phosphorylation [2, 7]. Beyond its role as a substrate, PIP2 directly modulates the activity of various ion channels, such as KCNQ and GABAA receptors, and organizes the actin cytoskeleton by interacting with proteins like profilin and gelsolin [8, 12]. Dysregulation of PIP2 signaling is implicated in a variety of human diseases, including cancer, neurological disorders such as Alzheimer's and bipolar disorder, and chronic pain [1, 4, 5]. While therapeutic intervention often targets the enzymes that metabolize PIP2, the molecule itself can be directly bound and sequestered by drugs like neomycin or experimental cell-penetrating peptides [11, 14]. Consequently, PIP2 is considered an attractive, albeit challenging, therapeutic target due to its ubiquitous role in maintaining cellular homeostasis and its involvement in pathological signaling pathways [4, 13].

Other names

PtdIns(4,5)P2PI(4,5)P2Phosphatidylinositol 4,5-diphosphate1,2-diacyl-sn-glycero-3-phospho-(1-D-myo-inositol 4,5-bisphosphate)

Direct binding and sequestration of the phospholipid headgroup to inhibit its interaction with effector proteins or its conversion into second messengers [11, 14].